Condition: Repeated Implantation Failure · Sponsor: Huazhong University of Science and Technology
The randomized, placebo-controlled multicenter trial is conducted in five centers in China. After screening and obtaining the signed informed consent , the participants are randomly divided into three groups: acupuncture group (Acu.+IVF），sham acupuncture group（Sham Acu. +IVF），and the control group (only IVF).
This description comes directly from the study's public registry record.
Cuihong Zheng, professor · 86-27-83663275 · chzheng@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
| Tongji Hospital,Tongji medical college,HUST | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04533295